These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 25533109)

  • 41. Intraoperative assessment of aortoiliac stenosis: role of papaverine-induced hyperemia.
    Brian JE; Gocio JC; Barnes RW
    J Ark Med Soc; 1984 Dec; 81(7):361-4. PubMed ID: 6240483
    [No Abstract]   [Full Text] [Related]  

  • 42. Assessment of renal artery stenosis severity by pressure gradient measurements.
    De Bruyne B; Manoharan G; Pijls NH; Verhamme K; Madaric J; Bartunek J; Vanderheyden M; Heyndrickx GR
    J Am Coll Cardiol; 2006 Nov; 48(9):1851-5. PubMed ID: 17084261
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predicting blood pressure response after renal artery stenting.
    Beck AW; Nolan BW; De Martino R; Yuo TH; Tanski WJ; Walsh DB; Powell RP; Cronenwett JL
    J Vasc Surg; 2010 Feb; 51(2):380-5; discussion 385. PubMed ID: 19939607
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Are demographic characteristics of hypertensive patients different with renal artery stenosis?].
    Jaboureck O; Mounier-Vehier C; Devos P; Lions C; Dequiedt P; Beregi JP; Carré A
    Arch Mal Coeur Vaiss; 2001 Aug; 94(8):828-33. PubMed ID: 11575212
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Defining Hemodynamic Significance of Renal Artery Stenosis: Insights From a Porcine Model of Graded Renal Artery Stenosis.
    Drieghe B; van Loon G; Decloedt A; Stuyvaert S; De Buyzere ML; Bové T; De Backer T
    Acad Radiol; 2023 Sep; 30 Suppl 1():S286-S294. PubMed ID: 37120404
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Objective performance goals of safety and blood pressure efficacy for clinical trials of renal artery bare metal stents in hypertensive patients with atherosclerotic renal artery stenosis.
    Rocha-Singh KJ; Novack V; Pencina M; D'Agostino R; Ansel G; Rosenfield K; Jaff MR
    Catheter Cardiovasc Interv; 2011 Nov; 78(5):779-89. PubMed ID: 21648052
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Renal autoregulation and passive pressure-flow relationships in diabetes and hypertension.
    Hill JV; Findon G; Appelhoff RJ; Endre ZH
    Am J Physiol Renal Physiol; 2010 Oct; 299(4):F837-44. PubMed ID: 20660017
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Renal interventions in the management of hypertension.
    Bob-Manuel T; Amoran OE; Jenkins C; Obafemi O; Tutor A; Tafur J
    Curr Opin Cardiol; 2021 Jul; 36(4):444-452. PubMed ID: 33929362
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Arteriography of the lower limbs with papaverine vasodilators].
    Tamisier JN; Hoeffel JC; Royer JR
    J Belge Radiol; 1973; 56(2):121-8. PubMed ID: 4719264
    [No Abstract]   [Full Text] [Related]  

  • 50. Postocclusive vascular responses in isolated perfused kidney of rabbits.
    Honda N; Morikawa A; Nihei H; Aizawa C; Yoshitoshi Y
    Am J Physiol; 1972 Jun; 222(6):1581-6. PubMed ID: 4337790
    [No Abstract]   [Full Text] [Related]  

  • 51. Renal angiographic and hemodynamic responses to vasodilators. A comparison of five agents in the dog.
    Ozer H; Hollenberg NK
    Invest Radiol; 1974; 9(6):473-8. PubMed ID: 4430587
    [No Abstract]   [Full Text] [Related]  

  • 52. Non-invasive Stenotic Renal Artery Haemodynamics by
    Mandaltsi A; Grytsan A; Odudu A; Kadziela J; Morris PD; Witkowski A; Ellam T; Kalra P; Marzo A
    Front Physiol; 2018; 9():1106. PubMed ID: 30174610
    [No Abstract]   [Full Text] [Related]  

  • 53. A new noninvasive and patient-specific hemodynamic index for the severity of renal stenosis and outcome of interventional treatment.
    Yu H; Khan M; Wu H; Du X; Chen R; Rollins DM; Fang X; Long J; Xu C; Sawchuk AP
    Int J Numer Method Biomed Eng; 2022 Jul; 38(7):e3611. PubMed ID: 35509229
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Muscle perfusion and control of breathing. Is there a neural link?
    Haouzi P; Marchal F; Huszczuk A
    Adv Exp Med Biol; 1995; 393():363-8. PubMed ID: 8629515
    [No Abstract]   [Full Text] [Related]  

  • 55. Does tetrahydroparaveroline contribute to the cardiovascular actions of dopamine?
    Halushka PV; Hoffmann PC
    Biochem Pharmacol; 1968 Sep; 17(9):1873-80. PubMed ID: 5688274
    [No Abstract]   [Full Text] [Related]  

  • 56. The Trueta phenomenon. Angiographic documentation in man.
    Siegelman SS; Goldman AG
    Radiology; 1968 Jun; 90(6):1084-9. PubMed ID: 5656726
    [No Abstract]   [Full Text] [Related]  

  • 57. [Effect of orciprenaline and papaverine on the pressure during the perfusion of the human placenta in experimental conditions].
    Zrubek H; Oleszczuk J; Pańczyk T; Sawulicka-Oleszczuk H; Hruczkowski L
    Ginekol Pol; 1978 Jun; 49(6):465-71. PubMed ID: 689476
    [No Abstract]   [Full Text] [Related]  

  • 58. [Papaverine and tubular kidney function].
    KLUETSCH K; HEIDLAND A
    Klin Wochenschr; 1960 Feb; 38():165-8. PubMed ID: 14410002
    [No Abstract]   [Full Text] [Related]  

  • 59. [Eupaverin effect on blood pressure in humans].
    SCHROCKSNADEL H; WALTINGER K
    Z Kreislaufforsch; 1948 May; 37(9-10):233-9. PubMed ID: 18878734
    [No Abstract]   [Full Text] [Related]  

  • 60. Functional Assessment of Intermediate Vascular Disease.
    Yaneva-Sirakova T; Serbezova I; Vassilev D
    Biomed Res Int; 2018; 2018():7619092. PubMed ID: 29850561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.